ARPIs Beneficial in Prostate Cancer
Researchers compared outcomes for patients randomized to receive androgen receptor pathway inhibitors, taxanes, or a physician's choice.
Medscape Medical News
source https://www.medscape.com/viewarticle/androgen-receptor-pathway-inhibitors-show-improved-outcomes-2024a1000g2n?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/androgen-receptor-pathway-inhibitors-show-improved-outcomes-2024a1000g2n?src=rss
Comments
Post a Comment